Concepedia

Russell R. Hoover

RR

12

Publications

1.1K

Citations

11

H-Index

1997

Active since

Affiliations

Pennsylvania State University(Current)

Whitehead Institute for Biomedical Research

Harvard University

Vertex Pharmaceuticals (United States)

University of Maryland, Baltimore

Russell R. Hoover is an author at Pennsylvania State University specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

1997–2017

12

Publications

12

Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336

Russell R. Hoover, François‐Xavier Mahon, Junia V. Melo et al. · Blood · 2002 · 247 citations · Full text

Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)

Ursula A. Germann, Brinley F. Furey, William Markland et al. · Molecular Cancer Therapeutics · 2017 · 225 citations

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

David G. Peters, Russell R. Hoover, Melissa J. Gerlach et al. · Blood · 2001 · 175 citations · Full text

Organization of the Human SP-A and SP-D Loci at 10q22-q23

Russell R. Hoover, Joanna Floros · American Journal of Respiratory Cell and Molecular Biology · 1998 · 113 citations

Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

Russell R. Hoover, Melissa J. Gerlach, Eugene Y. Koh et al. · Oncogene · 2001 · 87 citations

, , +11

Rows per page

1–5 of 12